Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05805033

Peri-Implant Soft Tissue Integration in Humans: Influence of Material

The purpose of this study is to compare the mucointegration of 2 types of surface roughness of zirconia abutments with titanium. The surface roughness will be machined and ultra-polished.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clémentine Canuel

Liège, 4000, Belgium

Location status: Recruiting

Location contact

Clémentine Canuel, MsD

CONTACT

[email protected]

+33679097264

About this study

After being informed about the study and potential risks, all participants give written informed consent and eligibility for study entry.

The day of the surgery, patients will be randomized in machined zirconia or ultra-polished zirconia.

After 8 weeks of healing, biopsy are separated in two groups according to the removal:

  • if the abutment come together with the surrounding soft tissues, it goes for a non decalcified histology for histometric measurements to determine the dimensions of biological width (sulcus depth, epithelial and connective adhesion)
  • if the abutment come separate of the surrounding tissue, the soft tissue goes for immunohistochemistry to analyse pro-inflammatory cells and vascularisation and the abutment for SEM analysis to calculate the percentage of adhesion of the cells on the abutment

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants have to voluntarily sign the informed consent form before any study related action
  • Patients aged 18 or over
  • Patients with one or more missing teeth in the maxillary or mandible area, seeking implant therapy
  • Men/women
  • Patients in good systemic health (ASA I/ II) and no contraindication for oral surgical interventions
  • Patients requiring a replacement of missing teeth; the tooth at the implant site(s) must have been extracted or lost at least 12 weeks before the date of implantation
  • At least 3 mm of fibrous mucosa in the bucco-lingual dimension
  • Full mouth plaque score (FMPI) lower than or equal to 25%
  • At least a diameter of 4 mm for the implant (regular diameter)

Exclusion criteria

  • Autoimmune disease requiring medical treatment
  • Medical conditions requiring prolonged use of steroids
  • Use of Bisphosphonates intravenously or more than 3 years of oral use
  • Infection (local or systemic) - patients with gingivitis or active local infection will undergo a medical treatment prior to the entrance to the study, and each individual will be evaluated for suitability; in case of a systemic infection, the evaluation will be based on medical anamneses, and if necessary, a patient will be referred to relevant medical tests
  • Current pregnancy or breastfeeding women
  • Alcoholism or chronical drug abuse
  • Immunocompromised patients
  • Uncontrolled diabetes
  • Smokers
  • Prisoners
  • Implant's diameter under 4 mm (narrow implant)
  • Conditions or circumstances, in the opinion of the investigator, which would prevent completion of the study or interference with analysis of study results, such as history of non-compliance, or unreliability

Treatment and study plan

Mucointegration

Other

Placement of abutment on a dental implant to study mucointegration

Primary outcomes

  1. Histomorphometry

    Time frame: 8 weeks of healing

    Height measure of biological width (sulcus depth, epithelial and connective adhesion)

  2. Immunohistology

    Time frame: 8 weeks of healing

    Analysis of the pro-inflammatory cells and vascularisation of the soft tissue + analysis of the percentage of cells adhesion on the abutment

Study contacts

Contact information is provided by the study sponsor or research team.

Clémentine Canuel, MsD

CONTACT

[email protected]

+33679097264

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Liege

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Apr 7, 2023
Registry last updated
Sep 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.